SCHEMBL10153370

SCHEMBL10153370

O=CC=Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.46
PTGS1 P23219 1/20 0.46
MAPT P10636 3/20 0.45
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
PLAU P00749 1/20 0.44
HTR3A P46098 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RAB9A P51151 1/20 0.38
NOS3 P29474 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13590024 0.86 ESR1 (0.43) PTGS2PTGS1MAPTHTR3EHTR3B
SCHEMBL13590027 0.82 S100B (0.50) MAPTALDH1A1CYP1A2KDM4ECYP2D6
SCHEMBL10153362 0.79 ITGB3 (0.39) MAPTHTR3EHTR3BHTR3AHTR3D
SCHEMBL13322468 0.77 CYP3A4 (0.38) PTGS2PTGS1MAPTCYP3A4TSHR
SCHEMBL19422196 0.75 MAPT (0.45) MAPTALDH1A1CYP3A4CYP2D6NOS3
SCHEMBL10153366 0.75 ALDH1A1 (0.44) MAPTALDH1A1KDM4ERAB9AS100B
SCHEMBL19422200 0.75 S100B (0.33) CYP3A4CYP2C9S100BTSHR
SCHEMBL13889193 0.74 SCN5A (0.38) MAPTALDH1A1CYP1A2KDM4ECYP2C9
SCHEMBL7625151 0.74 MAPT (0.47) PTGS2PTGS1MAPTHTR3EHTR3B
SCHEMBL13556406 0.72 KMT2A (0.38) MAPTALDH1A1KDM4ECYP3A4KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329907-B2 Autotaxin inhibitors MERCK PATENT GMBH (DE) 2012-12-11 US disclosed
US-20120015976-A1 AUTOTAXIN INHIBITORS MERCK PATENT GESELLSCHAFT MIT BESCHRANK TER HAFTUNG (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015976-A1 AUTOTAXIN INHIBITORS ENPP2, PLA2G12A, LPCAT1 PTGS2 1765/4885PTGS1 805/4885MAPT 2648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.